×
Entrez Id: 4214
Gene Symbol: MAP3K1
MAP3K1
Mammary Neoplasms
0.530
CausalMutation
CGI
×
Entrez Id: 472
Gene Symbol: ATM
ATM
Mammary Neoplasms
0.500
Biomarker
CTD_human
×
Entrez Id: 580
Gene Symbol: BARD1
BARD1
Mammary Neoplasms
0.450
Biomarker
CTD_human
×
Entrez Id: 83990
Gene Symbol: BRIP1
BRIP1
Mammary Neoplasms
0.450
Biomarker
CTD_human
×
Entrez Id: 5888
Gene Symbol: RAD51
RAD51
Mammary Neoplasms
0.400
Biomarker
CTD_human
×
Entrez Id: 8493
Gene Symbol: PPM1D
PPM1D
Mammary Neoplasms
0.380
Biomarker
CTD_human
×
Entrez Id: 3845
Gene Symbol: KRAS
KRAS
Mammary Neoplasms
0.350
Biomarker
CTD_human
×
Entrez Id: 7048
Gene Symbol: TGFBR2
TGFBR2
Mammary Neoplasms
0.340
GeneticVariation
UNIPROT
×
Entrez Id: 10664
Gene Symbol: CTCF
CTCF
Mammary Neoplasms
0.340
GeneticVariation
UNIPROT
×
Entrez Id: 5245
Gene Symbol: PHB
PHB
Mammary Neoplasms
0.330
Biomarker
CTD_human
SLC22A18
Mammary Neoplasms
0.320
Biomarker
CTD_human
×
Entrez Id: 8438
Gene Symbol: RAD54L
RAD54L
Mammary Neoplasms
0.310
Biomarker
CTD_human
×
Entrez Id: 4835
Gene Symbol: NQO2
NQO2
Mammary Neoplasms
0.300
Biomarker
CTD_human
×
Entrez Id: 1440
Gene Symbol: CSF3
CSF3
Mammary Neoplasms
0.320
Biomarker
CTD_human
Astemizole in the treatment of granulocyte colony-stimulating factor-induced bone pain.
7541186 1995
×
Entrez Id: 1440
Gene Symbol: CSF3
CSF3
Mammary Neoplasms
0.320
Therapeutic
CTD_human
Astemizole in the treatment of granulocyte colony-stimulating factor-induced bone pain.
7541186 1995
×
Entrez Id: 1440
Gene Symbol: CSF3
CSF3
Mammary Neoplasms
0.320
Biomarker
CTD_human
High-dose paclitaxel with granulocyte colony-stimulating factor in patients with advanced breast cancer refractory to anthracycline therapy: a European Cancer Center trial.
7543699 1995
×
Entrez Id: 1440
Gene Symbol: CSF3
CSF3
Mammary Neoplasms
0.320
Therapeutic
CTD_human
High-dose paclitaxel with granulocyte colony-stimulating factor in patients with advanced breast cancer refractory to anthracycline therapy: a European Cancer Center trial.
7543699 1995
×
Entrez Id: 1440
Gene Symbol: CSF3
CSF3
Mammary Neoplasms
0.320
Therapeutic
CTD_human
Phase I and pharmacologic study of paclitaxel and cisplatin with granulocyte colony-stimulating factor: neuromuscular toxicity is dose-limiting.
7692001 1993
×
Entrez Id: 1440
Gene Symbol: CSF3
CSF3
Mammary Neoplasms
0.320
Biomarker
CTD_human
Phase I and pharmacologic study of paclitaxel and cisplatin with granulocyte colony-stimulating factor: neuromuscular toxicity is dose-limiting.
7692001 1993
×
Entrez Id: 672
Gene Symbol: BRCA1
BRCA1
Mammary Neoplasms
0.500
Biomarker
CTD_human
Mutations in the BRCA1 gene in families with early-onset breast and ovarian cancer.
7894491 1994
×
Entrez Id: 1440
Gene Symbol: CSF3
CSF3
Mammary Neoplasms
0.320
Biomarker
CTD_human
Neurobiochemical changes from Taxol/Neupogen chemotherapy for metastatic breast carcinoma corresponds with suicidal depression.
9018096 1996
×
Entrez Id: 1440
Gene Symbol: CSF3
CSF3
Mammary Neoplasms
0.320
Therapeutic
CTD_human
Neurobiochemical changes from Taxol/Neupogen chemotherapy for metastatic breast carcinoma corresponds with suicidal depression.
9018096 1996
×
Entrez Id: 7057
Gene Symbol: THBS1
THBS1
Mammary Neoplasms
0.340
Therapeutic
CTD_human
Although the conjugated peptides were inactive in vivo, an unconjugated retro-inverso analog of the native TSP peptide inhibited breast tumor growth in a mouse xenograft model.
9309585 1997
×
Entrez Id: 1312
Gene Symbol: COMT
COMT
Mammary Neoplasms
0.380
Biomarker
CTD_human
An association between the allele coding for a low activity variant of catechol-O-methyltransferase and the risk for breast cancer.
9407957 1997
×
Entrez Id: 672
Gene Symbol: BRCA1
BRCA1
Mammary Neoplasms
0.500
Biomarker
CTD_human
Founder mutations in the BRCA1 gene in Polish families with breast-ovarian cancer.
10788334 2000